Unfortunately, those of us working on cases related to mass medical device errors or dangerous drugs appreciate that safety changes are usually only made in the aftermath of tragic problems. This is partly understandable, as in some cases it is difficult for anyone to know of a problem until some harm befalls someone. However, that does not mean that all mass problems are unavoidable or should not result accountability for those responsible.
The latest fungal meningitis outbreak–linked to tainted spinal steroid injections–offers a good illustration of these points.
As blog readers know, the outbreak has been traced to a pharmaceutical compounding company located in New England. Over 17,000 vials of contaminated product were shipped to at least 23 different states. Over 13,000 doses may have been given to patients between July and September of this year before the problem was identified and the injections were recalled. Thus far well over a hundred people have been infected, and at least twelve have died as a result.